Cargando…
Target and Cell Therapy for Atherosclerosis and CVD
Cardiovascular diseases (CVD) and, in particular, atherosclerosis, remain the main cause of death in the world today. Unfortunately, in most cases, CVD therapy begins after the onset of clinical symptoms and is aimed at eliminating them. In this regard, early pathogenetic therapy for CVD remains an...
Autores principales: | Markina, Yuliya V., Kirichenko, Tatiana V., Tolstik, Taisiya V., Bogatyreva, Anastasia I., Zotova, Ulyana S., Cherednichenko, Vadim R., Postnov, Anton Yu., Markin, Alexander M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299192/ https://www.ncbi.nlm.nih.gov/pubmed/37373454 http://dx.doi.org/10.3390/ijms241210308 |
Ejemplares similares
-
The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression
por: Markin, Alexander M., et al.
Publicado: (2023) -
The Role of Adipokines in Inflammatory Mechanisms of Obesity
por: Kirichenko, Tatiana V., et al.
Publicado: (2022) -
The Role of Macrophages in the Pathogenesis of Atherosclerosis
por: Blagov, Alexander V., et al.
Publicado: (2023) -
Molecular and Cellular Mechanisms of Osteoporosis
por: Zhivodernikov, Ivan V., et al.
Publicado: (2023) -
Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis at Low Cardiovascular Risk
por: Gerasimova, Elena V., et al.
Publicado: (2023)